-
Abedon ST. 2011. Bacteriophage prehistory: is or is not Hankin, 1896, a phage reference? Bacteriophage, 1: 174-178.
doi: 10.4161/bact.1.3.16591
-
Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. 2011. Phage Treatment of human infections. Bacteriophage, 1: 66-85.
doi: 10.4161/bact.1.2.15845
-
Bernstein D, Fischetti VA. 1997. Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci. US Patent 05604109.
-
Briersa Y, Walmagha M, Van Puyenbroecka V, Cornelissena A, Cenensb W, Aertsenb A, Oliveirac H, Azeredoc J, Verweend G, Pirnayd JP, Miller S, Volckaerta G, Lavignea R. 2014. Engineered Endolysin-Based "Artilysins" To Combat Multidrug-Resistant Gram-Negative Pathogens. MBio, 5: e01379-14.
doi: 10.1128/mBio.01379-14
-
Bruynoghe R, Maisin J. 1921. Essais de thérapeutique au moyen du bactériophage du Staphylocoque. Compt Rend Soc Biol, 85: 1120-1121. (In French)
-
Cutter CN, Dorsa WJ, Siragusa GR. 1996. A rapid microbial ATP bioluminescence assay for meat carcasses. Dairy, Food & Environ. San, 16: 726-736.
-
d'Herelle FH. Sur un microbe invisible antagoniste des bacilles dysenteriques. 1917. C R Acad Sci Gen, 165: 373-375. (In French)
-
d'Hérelle F. 1931. Bacteriophagy and recovery from infectious disease. Can Med Assoc J. 24: 619-628
-
Filatova LYu, Levashov AV, Dmitrieva NF, Eshchina AS, Klyachko NL. 2008. Encapsulation of enzyme lysing group A streptococci to improve its stability. Proc XVIth Int Workshop on Bioencapsulation. Marison I, Poncelet D, Eds., Dublin, Ireland, pp1-4.
-
Fischetti VA. 2005. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol, 13: 491-496.
doi: 10.1016/j.tim.2005.08.007
-
Fischetti VA, Gotschlich EC, Bernheimer AW. 1971. Purification and Physical Properties of Group C Streptococcal Phage Associated Lysin. J Exp Med, 133: 1105-1117.
doi: 10.1084/jem.133.5.1105
-
Fischetti VA, Loomis L. 1999. Prophylactic and therapeutic treatment of group A streptococcal infection. US Patent 5, 985, 271 A. Spiez, Switzerland.
-
Florin P. 2006. Bacterial Contamination in a Field Hospital. Proc CBMTS-Ⅵ. Spiez, Switzerland.
-
Hasan JAK, S Garg, L Loomis, D Miller, and RR Colwell. 1997. A rapid surface-monitoring method for bacteria employing ATP bioluminescence. Abstr 97th General Meeting of Am. Soc. Microbiol, abstr I-026.
-
Hankin ME. 1896. L'action bactéricide des eaux de la Jumna et du Gange sur le vibrion du choléra. Ann Inst Pasteur (Paris), 10: 511-523. (In French)
-
Harper DR, Kutter E. 2008. Bacteriophage: therapeutic use. Encyclopedia of Life Sciences. Chichester, UK: John Wiley & Sons, Ltd. ; pp1-7.
-
Ho K. 2001. Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era. Perspect Biol Med, 44: 1-16.
-
Hoopes JT, Stark CJ, Kim HA, Sussman DJ, Donovan DM, Nelson DC. 2009. Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi. Appl Environ Microbiol, 75: 1388-1394.
doi: 10.1128/AEM.02195-08
-
Krause RM.1958. Studies on the Bacteriophages of Hemolytic Streptococci. J Exp Med, 108: 803-821.
doi: 10.1084/jem.108.6.803
-
Klyachko NL, Dmitrieva NF, Eshchina AS, Ignatenko OV, Filatova LY, Rainina EI, Kazarov AK, Levashov AV. 2008. Bacteriophage enzyme for the prevention and treatment of bacterial infections: stability and stabilization of the enzyme lysing Streptococcus pyogenes cells. Russ J Bioorganic Chem, 34: 375-379.
doi: 10.1134/S1068162008030217
-
Maxted WR. 1957. The Active Agent in Nascent Phage Lysis of Streptococci. J Gen Micro, 16: 585-595.
-
Nelson D, Loomis L, Fischetti VA. 2001. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using bacteriophage lytic enzyme, Proc Natl Acad Sci U S A, 98:4107-4112.
doi: 10.1073/pnas.061038398
-
Roach DR, Khatibi PA, Bischoff KM, Hughes SR and Donovan DM. 2013. Bacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations. Biotechnol Biofuels, 6:20.
doi: 10.1186/1754-6834-6-20
-
Schmelcher M, Powella A, Beckera S, Campb M, Donovan D. 2012. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis -causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol, 78: 2297-2305.
doi: 10.1128/AEM.07050-11
-
Schuch R, Nelso D, Fischetti V. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature, 418: 884-889.
doi: 10.1038/nature01026
-
Siragusa GR, Cutter CN, Dorsa WJ, Koohmaraie M. 1995. Use of a rapid microbial ATP bio-luminescence assay to detect contamination on beef and pork carcasses. J Food Prot, 58: 770-775.
doi: 10.4315/0362-028X-58.7.770
-
Siragusa GR, Dorsa WJ, Cutter CN, Perino LJ, Koohmaraie M. 1996. Use of a newly developed rapid microbial ATP bioluminescence assay to detect microbial contamination on poultry carcasses. J Biolumin Chemilumin, 11: 297-301.
doi: 10.1002/(ISSN)1099-1271
-
Stopa PJ, Tieman D, Coon PA, Milton MM, Paterno D. 1999. Detection of biological aerosols by luminescence techniques. Field Anal Chem Technol, 3: 283-290.
doi: 10.1002/(ISSN)1520-6521
-
Sulakvelidze A, Barrow P. 2005. Phage therapy in animals and agribusiness. In: Bacteriophages: Biology and Applications. Kutter E, Sulakvelidze. Boca Raton: CRC Press. pp335-380.
-
Summers WC. 2001. Bacteriophage therapy. Annu Rev Microbiol, 55: 437-451.
doi: 10.1146/annurev.micro.55.1.437
-
Trudil D. 2002. Use of phage associated lytic enzymes for rapid detection of bacterial contaminants (priority date 1999). US Patent 6395504.
-
Trudil D, Rainina E. 2006. Use of Lytic Enzymes for Microbiological Decontamination of Sensitive Facilities. Proc 5TH SISPAT, Singapore.
-
Twort FW. 1915. An investigation on the nature of ultramicroscopic viruses. Lancet, 186: 1241-1246.
doi: 10.1016/S0140-6736(01)20383-3
-
Yang H, Zhang Y, Yu J, Huang Y, Zhang XE, Wei H. 2014. Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Ch, 58: 536-542.
doi: 10.1128/AAC.01793-13